Natural killer cells (donor-derived NK cells)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Natural killer cells (donor-derived NK cells), covering 2024-01-17 to 2024-01-17. Get the full timeline:
Most recent: Clinical Trial Update: Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia [Phase 1, Phase 2]